<?xml version="1.0" encoding="UTF-8"?>
<p>One important feature of COVID‐19 is its effect on the blood coagulation system. The Royal College of Obstetricians and Gynecologists (RCOG) advised clinicians that infection with COVID‐19 may increase the risk of venous thromboembolism and that this risk may be compounded by reduced mobility due to self‐separation. Thus, RCOG recommended that pregnant individuals hospitalized with COVID‐19 should receive prophylactic low‐molecular‐weight heparin to reduce the risk of pulmonary embolism.
 <xref rid="jog14384-bib-0049" ref-type="ref">
  <sup>49</sup>
 </xref>
</p>
